1. Home
  2. COGT vs ODC Comparison

COGT vs ODC Comparison

Compare COGT & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • ODC
  • Stock Information
  • Founded
  • COGT 2014
  • ODC 1941
  • Country
  • COGT United States
  • ODC United States
  • Employees
  • COGT N/A
  • ODC N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • ODC Miscellaneous manufacturing industries
  • Sector
  • COGT Health Care
  • ODC Consumer Discretionary
  • Exchange
  • COGT Nasdaq
  • ODC Nasdaq
  • Market Cap
  • COGT 1.1B
  • ODC 959.4M
  • IPO Year
  • COGT 2018
  • ODC N/A
  • Fundamental
  • Price
  • COGT $12.36
  • ODC $67.77
  • Analyst Decision
  • COGT Strong Buy
  • ODC
  • Analyst Count
  • COGT 11
  • ODC 0
  • Target Price
  • COGT $21.20
  • ODC N/A
  • AVG Volume (30 Days)
  • COGT 1.5M
  • ODC 67.7K
  • Earning Date
  • COGT 11-11-2025
  • ODC 10-09-2025
  • Dividend Yield
  • COGT N/A
  • ODC 1.05%
  • EPS Growth
  • COGT N/A
  • ODC 17.38
  • EPS
  • COGT N/A
  • ODC 3.40
  • Revenue
  • COGT N/A
  • ODC $474,062,000.00
  • Revenue This Year
  • COGT N/A
  • ODC N/A
  • Revenue Next Year
  • COGT N/A
  • ODC N/A
  • P/E Ratio
  • COGT N/A
  • ODC $19.92
  • Revenue Growth
  • COGT N/A
  • ODC 9.92
  • 52 Week Low
  • COGT $3.72
  • ODC $32.15
  • 52 Week High
  • COGT $13.50
  • ODC $69.76
  • Technical
  • Relative Strength Index (RSI)
  • COGT 52.66
  • ODC 74.50
  • Support Level
  • COGT $12.28
  • ODC $65.50
  • Resistance Level
  • COGT $13.13
  • ODC $66.93
  • Average True Range (ATR)
  • COGT 0.52
  • ODC 1.54
  • MACD
  • COGT -0.08
  • ODC 0.52
  • Stochastic Oscillator
  • COGT 30.06
  • ODC 82.96

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: